These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 2997046)

  • 1. Evaluation of a new bronchodilator, Formoterol, using biochemical parameters.
    Yamakido M; Inamizu T; Ikuta T; Onari K; Tanabe M; Nishimoto Y
    Int J Clin Pharmacol Ther Toxicol; 1985 Sep; 23(9):461-8. PubMed ID: 2997046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study with cumulative doses of formoterol and salbutamol in children with asthma.
    Foucard T; Lönnerholm G
    Eur Respir J; 1991 Nov; 4(10):1174-7. PubMed ID: 1687130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhaled formoterol during one year in asthma: a comparison with salbutamol.
    Arvidsson P; Larsson S; Löfdahl CG; Melander B; Svedmyr N; Wåhlander L
    Eur Respir J; 1991 Nov; 4(10):1168-73. PubMed ID: 1687129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-invasive evaluation of hemodynamic, tremorogenic and biochemical effects in response to beta-adrenoceptor stimulation.
    Adamus WS; Jansen U; Schilling JC
    Methods Find Exp Clin Pharmacol; 1989 Jan; 11(1):57-62. PubMed ID: 2565995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pulmonary and extra-pulmonary effects of high-dose formoterol in COPD: a comparison with salbutamol.
    Goldkorn A; Diotto P; Burgess C; Weatherall M; Holt S; Beasley R; Siebers R
    Respirology; 2004 Mar; 9(1):102-8. PubMed ID: 14982610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the cardiovascular and metabolic effects of formoterol, salbutamol and fenoterol.
    Bremner P; Woodman K; Burgess C; Crane J; Purdie G; Pearce N; Beasley R
    Eur Respir J; 1993 Feb; 6(2):204-10. PubMed ID: 8095240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and tolerability of high-dose formoterol (via Aerolizer) and salbutamol in patients with chronic obstructive pulmonary disease.
    Rosenkranz B; Rouzier R; Kruse M; Dobson C; Ayre G; Horowitz A; Fitoussi S
    Respir Med; 2006 Apr; 100(4):666-72. PubMed ID: 16303295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Formoterol as inhalation powder in the treatment of patients with reversible obstructive lung diseases. A 3-month placebo-controlled comparison of the effects of formoterol and salbutamol, followed by a 12-month period with formoterol alone].
    Steffensen IE; Faurschou P
    Ugeskr Laeger; 1996 Dec; 158(49):7092-6. PubMed ID: 8999618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bronchial asthma treated with long-acting beta 2 agonist. Comparison between formoterol (12 mu/g) inhaled twice daily and salbutamol (200 mu/g) inhaled 4 times daily].
    Sprogøe-Jakobsen U; Viktrup L; Davidsen O; Viskum K
    Ugeskr Laeger; 1992 Nov; 154(47):3325-8. PubMed ID: 1361083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged bronchodilating effect of formoterol versus procaterol in bronchial asthma.
    Chetta A; Del Donno M; Maiocchi G; Pisi G; Moretti D; Olivieri D
    Ann Allergy; 1993 Feb; 70(2):171-4. PubMed ID: 8430925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long duration of airway but not systemic effects of inhaled formoterol in asthmatic patients.
    Lötvall J; Ankerst J
    Respir Med; 2008 Mar; 102(3):449-56. PubMed ID: 18023335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy, tolerability, and effect on asthma-related quality of life of formoterol bid via multidose dry powder inhaler and albuterol QID via metered dose inhaler in patients with persistent asthma: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study.
    Busse W; Levine B; Andriano K; Lavecchia C; Yegen U
    Clin Ther; 2004 Oct; 26(10):1587-98. PubMed ID: 15598475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inquiry into the mechanism of long-acting bronchodilators].
    Bao Y; Lemoine H
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Jun; 20(3):191-6. PubMed ID: 11367704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bronchodilating and cardiovascular effects of intraduodenally and orally administered clenbuterol in dogs.
    Kato H; Nakayama K; Takata Y; Kurihara J; Sakai T; Iwata K; Yamamoto I
    Arzneimittelforschung; 1985; 35(7):1037-41. PubMed ID: 4052137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relaxant effects and durations of action of formoterol and salmeterol on the isolated human bronchus.
    Naline E; Zhang Y; Qian Y; Mairon N; Anderson GP; Grandordy B; Advenier C
    Eur Respir J; 1994 May; 7(5):914-20. PubMed ID: 7914176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TPI 1020, a novel anti-inflammatory, nitric oxide donating compound, potentiates the bronchodilator effects of salbutamol in conscious guinea-pigs.
    Turner DL; Ferrari N; Ford WR; Kidd EJ; Paquet L; Renzi P; Broadley KJ
    Eur J Pharmacol; 2010 Sep; 641(2-3):213-9. PubMed ID: 20639142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerance to bronchodilation during treatment with long-acting beta-agonists, a randomised controlled trial.
    Haney S; Hancox RJ
    Respir Res; 2005 Sep; 6(1):107. PubMed ID: 16168062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the haemodynamic and hypokalaemic effects of inhaled pirbuterol and salbutamol.
    Windom H; Grainger J; Burgess C; Crane J; Pearce N; Beasley R
    N Z Med J; 1990 Jun; 103(891):259-61. PubMed ID: 1972557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma.
    Aziz I; Hall IP; McFarlane LC; Lipworth BJ
    J Allergy Clin Immunol; 1998 Mar; 101(3):337-41. PubMed ID: 9525449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, double-blind, double-dummy, safety crossover trial comparing cumulative doses up to 96 microg of formoterol delivered via an HFA-134a-propelled pMDI vs. same cumulative doses of formoterol DPI and placebo in asthmatic patients.
    Molimard M; Guenolé E; Duvauchelle T; Vicaut E; Lefrançois G
    Respiration; 2005; 72 Suppl 1():28-34. PubMed ID: 15915010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.